What is the treatment for supraventricular tachycardia (SVT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The treatment for supraventricular tachycardia (SVT) should begin with vagal maneuvers, followed by intravenous adenosine as the first-line medication, as recommended by the most recent guidelines 1.

Initial Treatment

The initial approach to treating SVT involves increasing parasympathetic tone through vagal maneuvers such as the Valsalva maneuver or carotid sinus massage. These maneuvers can quickly terminate the episode and are considered the first line of treatment.

Adenosine Therapy

If vagal maneuvers are unsuccessful, intravenous adenosine is the next step, typically given as a 6 mg rapid bolus followed by a saline flush 1. If this initial dose is unsuccessful, a 12 mg dose can be administered, and repeated once if needed. Adenosine is effective for conversion of orthodromic AVRT in 90% to 95% of patients, with minor and brief side effects occurring in approximately 30% of patients.

Alternative Treatments

For persistent SVT, calcium channel blockers like verapamil or diltiazem, or beta-blockers such as metoprolol may be used, although their recommendations have been downgraded in recent guidelines 1. In hemodynamically unstable patients, immediate synchronized cardioversion at 50-100 joules is indicated.

Long-term Management

For long-term management, options include catheter ablation for definitive treatment or maintenance medications such as beta-blockers, although the use of certain antiarrhythmics has been downgraded or is no longer recommended due to potential side effects and the availability of more effective treatments 1.

Key points to consider in the treatment of SVT include:

  • Vagal maneuvers as the initial treatment
  • Adenosine as the first-line medication for acute treatment
  • Consideration of calcium channel blockers or beta-blockers for persistent SVT, with caution due to downgraded recommendations
  • Synchronized cardioversion for hemodynamically unstable patients
  • Catheter ablation or maintenance medications for long-term management, with careful selection based on the latest guidelines.

From the FDA Drug Label

By interrupting reentry at the AV node, verapamil can restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardias (PSVT), including PSVT associated with Wolff-Parkinson-White syndrome. The treatment for supraventricular tachycardia (SVT) is verapamil, which can restore normal sinus rhythm by interrupting reentry at the AV node 2.

  • Key points:
    • Verapamil is effective in treating paroxysmal supraventricular tachycardias (PSVT)
    • It works by interrupting reentry at the AV node
    • It can restore normal sinus rhythm in patients with SVT, including those with Wolff-Parkinson-White syndrome

From the Research

Treatment Options for Supraventricular Tachycardia (SVT)

The treatment for SVT can be categorized into acute and long-term management.

  • Acute management includes:
    • Vagal maneuvers, which can terminate the arrhythmia in some cases 3, 4, 5
    • Adenosine, which is effective in converting SVT to sinus rhythm 3, 4, 6, 7
    • Calcium channel blockers (e.g., diltiazem or verapamil) or beta blockers (e.g., metoprolol) 3, 4
  • Long-term management includes:
    • Calcium channel blockers or beta blockers 3, 4
    • Class Ic antiarrhythmics (e.g., flecainide or propafenone) 3
    • Class Ia antiarrhythmics (e.g., quinidine, procainamide, or disopyramide), although these are used less often due to their modest effectiveness and adverse effects 3
    • Class III antiarrhythmics (e.g., amiodarone, sotalol, or dofetilide), which are effective but have potential adverse effects and should be administered in consultation with a cardiologist 3
    • Catheter ablation, which has a high success rate and is the preferred treatment for symptomatic patients with Wolff-Parkinson-White syndrome 3, 4

Comparison of Treatment Options

Studies have compared the effectiveness of different treatment options for SVT.

  • Adenosine and verapamil have been shown to be equally effective in converting out-of-hospital SVT to sinus rhythm 7
  • Vagal maneuvers have been found to be safe and effective in young, otherwise healthy patients, but may not be suitable for older patients with coronary or cerebrovascular disease 5
  • Clinical decision analysis suggests that young patients should be treated initially with vagal maneuvers, while older patients should be treated initially with verapamil 5

Considerations for Treatment

When selecting a treatment option for SVT, several factors should be considered, including:

  • The patient's age and underlying health status 5
  • The frequency and severity of symptoms 4
  • The risk of adverse effects associated with different treatment options 3, 6, 7
  • The patient's preference for treatment 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Supraventricular tachycardia: An overview of diagnosis and management.

Clinical medicine (London, England), 2020

Research

Adenosine and the treatment of supraventricular tachycardia.

The American journal of medicine, 1992

Research

Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.